Pages that link to "Q40492896"

The following pages link to Differential protein acetylation induced by novel histone deacetylase inhibitors (Q40492896):

Displaying 20 items.

• Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents (Q21198868) (← links)
• Quantitative proteomic analysis of post-translational modifications of human histones (Q28235630) (← links)
• Circadian Rhythm Disruption in Cancer Biology (Q28972554) (← links)
• A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma (Q33413857) (← links)
• Class-specific histone/protein deacetylase inhibition protects against renal ischemia reperfusion injury and fibrosis formation (Q33859326) (← links)
• Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition (Q35005604) (← links)
• ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia (Q35751114) (← links)
• Therapeutic application of histone deacetylase inhibitors for central nervous system disorders (Q37283454) (← links)
• Recent advances in the development of polyamine analogues as antitumor agents (Q37522449) (← links)
• Histone deacetylase inhibitors (HDACIs). Structure--activity relationships: history and new QSAR perspectives (Q37693855) (← links)
• Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives. (Q38031633) (← links)
• Epigenetic regulation of soluble guanylate cyclase (sGC) β1 in breast cancer cells (Q38765639) (← links)
• Development of a high-content screening assay panel to accelerate mechanism of action studies for oncology research (Q39329862) (← links)
• Epigenetic regulation of cardiac muscle-specific genes in H9c2 cells by Interleukin-18 and histone deacetylase inhibitor m-carboxycinnamic acid bis-hydroxamide (Q40010061) (← links)
• Chemistry, biology, and QSAR studies of substituted biaryl hydroxamates and mercaptoacetamides as HDAC inhibitors-nanomolar-potency inhibitors of pancreatic cancer cell growth (Q40027441) (← links)
• R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies (Q40052320) (← links)
• The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells (Q40105829) (← links)
• Epigenetic modifiers: basic understanding and clinical development. (Q45976173) (← links)
• Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS. (Q47922062) (← links)
• Interest of new alkylsulfonylhydrazide-type compound in the treatment of alcohol use disorders (Q88527614) (← links)